Knee implant materials put to the test in human cells
NCT ID NCT07671521
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test whether common orthopedic materials, like titanium alloy and polylactic acid (PLA), are safe for use in knee surgery. Researchers will expose human tissue samples from 50 knee replacement patients to these materials in the lab. They will check for cell damage, inflammation, and other signs of toxicity to ensure the materials are safe before moving to animal or human trials.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
titanium alloy and polylactic acid (PLA) materials, with platelet-rich plasma (PRP)
What this could lead to
If successful, this study could confirm that these materials are safe and help improve how well knee grafts heal, leading to better surgical outcomes.
What could go wrong
This is a very early lab study using cells in a dish, not in people. Results may not predict what happens inside the body, and further testing is needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KNEE OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IRCCS Rizzoli Orthopedic Institute
Bologna, 40136, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••